Researchers at the University of Tsukuba conducted a three-year observational study (January 2019–December 2021) using a ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Readmission rate improvements often attributed to an Affordable Care Act policy fining hospitals with higher-than-expected readmissions may actually be the result of changes in how visits were being ...

The SGLT2 inhibitors, as a class, lead to similar treatment benefits at comparable clinical doses, although there are some discrepancies between them, particularly when dapagliflozin (Farxiga; ...

Extensive and growing evidence continues to reinforce fezolinetant as an effective treatment for moderate to severe VMS associated with menopause Preliminary analysis from OPTION-VMS observational ...